2019
DOI: 10.1016/j.jsps.2019.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Novel oral dosage regimen based on self-nanoemulsifying drug delivery systems for codelivery of phytochemicals – Curcumin and thymoquinone

Abstract: Graphical abstractCurcumin (CUR) and Thymoquinone (THQ) were formulated using self-nanoemulsifying drug delivery systems (SNEDDS) as combined dosage form. The solubility, stability and drug release in dissolution media were significantly improved by the SNEDDS formulation compare to the raw drug powder.Schematic Diagram: Dosage form design and CUR & THQ release after oral administration of lipid-based SNEDDS formulations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

10
34
0
3

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 66 publications
(47 citation statements)
references
References 42 publications
10
34
0
3
Order By: Relevance
“…(b) The inclusion of BSO, which possess good self-emulsification properties as confirmed by the significantly (p < 0.05) lower droplet size of both formulations containing BSO (F3 and F6, Figure 3). Similar low droplet size results were reported with other SNEDDS systems containing BSO [46]. (c) The inclusion of the water soluble cosolvent TcP in the formulation.…”
Section: Discussionsupporting
confidence: 85%
See 4 more Smart Citations
“…(b) The inclusion of BSO, which possess good self-emulsification properties as confirmed by the significantly (p < 0.05) lower droplet size of both formulations containing BSO (F3 and F6, Figure 3). Similar low droplet size results were reported with other SNEDDS systems containing BSO [46]. (c) The inclusion of the water soluble cosolvent TcP in the formulation.…”
Section: Discussionsupporting
confidence: 85%
“…The significant difference between CUR and PP release from the same adsorbent could be attributed to the strong physical bonds developed between A300 and CUR, which hindered drug release upon exposure to GI fluids. Similar results were observed with the adsorbents Syloid and NUS, and could be correlated with one or more the following factors: smaller pore size, longer pore channels and/or developed hydrogen bonding between the drug and adsorbent [46,[54][55][56].…”
Section: Discussionsupporting
confidence: 83%
See 3 more Smart Citations